Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U Trial)
Joel M. Gelfand, Daniel B. Shin, Abass Alavi, et al.
Journal of Investigative Dermatology (2019) Vol. 140, Iss. 1, pp. 85-93.e2
Open Access | Times Cited: 97

Showing 26-50 of 97 citing articles:

Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-Analysis
April W. Armstrong, Richard B. Warren, Yichen Zhong, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 11, pp. 2839-2857
Open Access | Times Cited: 19
Mechanisms of Vascular Inflammation and Potential Therapeutic Targets: A Position Paper From the ESH Working Group on Small Arteries
Francisco J. Rios, Carolina De Ciuceis, Georgios Georgiopoulos, et al.
Hypertension (2024) Vol. 81, Iss. 6, pp. 1218-1232
Closed Access | Times Cited: 8
Psoriasis and Molecular Target Therapies: Evidence of Efficacy in Preventing Cardiovascular Comorbidities
Luca Potestio, Nello Tommasino, Giuseppe Lauletta, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 4, pp. 841-852
Open Access | Times Cited: 6
Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 1. «Conceptos y manejo general de la psoriasis con terapia biológica»
J.M. Carrascosa, L. Puig, I. Belinchón, et al.
Actas Dermo-Sifiliográficas (2021) Vol. 113, Iss. 3, pp. 261-277
Open Access | Times Cited: 39
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis
Joel M. Gelfand, Daniel B. Shin, April Armstrong, et al.
JAMA Dermatology (2022) Vol. 158, Iss. 12, pp. 1394-1394
Open Access | Times Cited: 27
Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 2 «Manejo de poblaciones especiales, pacientes con comorbilidad y gestión del riesgo»
J.M. Carrascosa, L. Puig, I. Belinchón, et al.
Actas Dermo-Sifiliográficas (2022) Vol. 113, Iss. 6, pp. 583-609
Open Access | Times Cited: 24
Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 1)
Jo Lambert, Siegfried Segaert, Pierre‐Dominique Ghislain, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 8, pp. 1654-1665
Open Access | Times Cited: 37
GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases
Nehal N. Mehta, Amit K. Dey, Reethika Maddineni, et al.
American Journal of Preventive Cardiology (2020) Vol. 4, pp. 100120-100120
Open Access | Times Cited: 36
Chronic inflammatory diseases, myocardial function and cardioprotection
Antigone Lazou, Ignatios Ikonomidis, Monika Barteková, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 23, pp. 5357-5374
Open Access | Times Cited: 35
Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies
Deepak Balak, Stefano Piaserico, Ismail Kasujee
Psoriasis Targets and Therapy (2021) Vol. Volume 11, pp. 151-168
Open Access | Times Cited: 30
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications
Joseph F. Merola, Iain B. McInnes, Atul Deodhar, et al.
Rheumatology and Therapy (2022) Vol. 9, Iss. 3, pp. 935-955
Open Access | Times Cited: 21
Does Systemic Anti-Psoriatic Treatment Impact the Risk of Cardiovascular Disease? A Review Over Cardiovascular Imaging Studies
Hannah Kaiser, Charlotte Näslund‐Koch, Amanda Kvist‐Hansen, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 2, pp. 303-321
Open Access | Times Cited: 4
T Cells in Autoimmunity-Associated Cardiovascular Diseases
Daniella M. Schwartz, Aarohan M Burma, Moses M. Kitakule, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 32
Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk
C. Elise Kleyn, Peter S. Talbot, Nehal N. Mehta, et al.
Acta Dermato Venereologica (2019) Vol. 100, Iss. 1, pp. 1-8
Open Access | Times Cited: 30
New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies
Di Yan, Andrew Blauvelt, Amit K. Dey, et al.
Journal of Investigative Dermatology (2021) Vol. 141, Iss. 10, pp. 2328-2337
Open Access | Times Cited: 27
IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis
Xing Wang, Hannah Kaiser, Amanda Kvist‐Hansen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 555-555
Open Access | Times Cited: 17
Glycobiology of psoriasis: A review
Yuchen Yang, Xin Zhou, Wenhui Wang, et al.
Journal of Autoimmunity (2025) Vol. 151, pp. 103361-103361
Open Access
Spanish Working Group in Crohn’s Disease and Ulcerative Colitis (GETECCU) position paper on cardiovascular disease in patients with inflammatory bowel disease
Ignacio Marín‐Jiménez, Daniel Carpio, Vicent Hernández, et al.
Gastroenterología y Hepatología (English Edition) (2025), pp. 502314-502314
Closed Access
The Gut-Skin Axis in Psoriasis: Evidence-Based Insights from a Meta-Analysis on Probiotics-Synbiotics-Mediated Microbiota Interventions
Nurlinah Amalia, Danar Wicaksono, Elvan Wiyarta, et al.
Medicine in Microecology (2025), pp. 100126-100126
Open Access
Biologics for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Network Meta-analysis
Mark Lebwohl, André Lopes Carvalho, Akihiko Asahina, et al.
Dermatology and Therapy (2025)
Open Access
Cardiovascular disease risk in psoriatic disease: mechanisms and implications for clinical practice
John Medamana, Joel M. Gelfand, Brittany Weber, et al.
Current Opinion in Rheumatology (2025)
Closed Access
Adverse Events Associated With Anti-IL-23 Agents: Clinical Evidence and Possible Mechanisms
Yi Ru, Xiaojie Ding, Ying Luo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 23
Cardiovascular comorbidities in psoriasis (Review)
D Brănişteanu, Alin Codruț Nicolescu, Daniel Brănişteanu, et al.
Experimental and Therapeutic Medicine (2021) Vol. 23, Iss. 2
Open Access | Times Cited: 23
Racial and ethnic diversity of US participants in clinical trials for acne, atopic dermatitis, and psoriasis: a comprehensive review
Anjana Sevagamoorthy, Patrick G. Sockler, Christine C. Akoh, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 8, pp. 3086-3097
Closed Access | Times Cited: 15
Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
Robert Ramer, Burkhard Hinz
Cells (2022) Vol. 11, Iss. 24, pp. 4102-4102
Open Access | Times Cited: 15

Scroll to top